TOCILIZUMAB MONOTHERAPY IN PATIENTS WHERE METHOTREXATE IS CONSIDERED INAPPROPRIATE- A CANADIAN COST-UTILITY ANALYSIS
Abstract
Authors
J. Marino A. Diamantopoulos M. Duong J.M. Boam
J. Marino A. Diamantopoulos M. Duong J.M. Boam
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now